Advaxis (ADXS) Extends Rally: Gains 50% in a Week

Clinical stage biotechnology company Advaxis (NASDAQ: ADXS) saw its stock soar by as much as 22% yesterday and the trend has continued in premarket trading this morning.

The Advaxis stock has climbed by as much as 18% this morning and it is likely that the stock is going to come into focus among many investors. However, it should be noted that there has been no news regarding the company’s business that could have sparked such a rally.

Related:  Why is Advaxis (ADXS) Weak Despite Positive Developments?

The rally could well be related to development back on December 22 last year. At the time, Advaxis announced that the NASDAQ Capital Market had approved its request to move its stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market.

ADXS stock started trading on the Nasdaq Capital Market on December 24. Considering the gains that the Advaxis stock has recorded this week so far, it might be a good idea to keep an eye on it today.

Related:  Bethesda's long term growing stock to get 2x returns: Northwest Biotherapeutics (NWBO)


Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.